F8 and hemophilia: Repeated oral delivery of plant cells expressing CTB-fused antigen has been effective in suppression of inhibitor formation against FVIII in hemophilia A mice and against FIX in hemophilia B mice and dogs that were subsequently treated with intravenous FVIII or FIX therapy (18–21).